First in human phase i/II clinical trial of ONC-392: preserving ctla-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy…
Ended Project Grant Awarded Last action
- Award ID
- R44CA250824
- Recipient
-
Oncoc4 Inc. UEI JAAPHKL5VEJ8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,214,353
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding
-
- $4,276,235.46 Federal
- $938,117.73 Non-federal
- Place of performance
- Rockville, MD 20850, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $1,000,000 | $0 | |
| Amendment | $1,000,000 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $1,000,000 | $0 | |
| Amendment | $1,000,000 | $1,000,000 | |
| Amendment | -$61,882 | $0 | |
| Amendment | -$61,882 | -$61,882 | |
| Original award | $400,000 | $0 |
Quick answers
Who received award R44CA250824?
R44CA250824 was awarded to Oncoc4 Inc. by National Cancer Institute (National Institutes of Health) on April 3, 2020.
How much is award R44CA250824 worth?
$5,214,353 has been obligated on R44CA250824: $4,276,235 in federal funding and $938,118 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award